David Meeker, CEO of Rhythm, discusses genetic obesities, the company’s drug Imcivree, and his plans to expand the use of the drug beyond the initial approved indications.

Targeting a Common Pathway in Genetic Forms of Obesity

<p>RARECast is a Global Genes podcast hosted by award-winning journalist Daniel Levine. It focuses on the intersection of rare disease with business, science, and policy. </p>

Business

RARECast is a Global Genes podcast hosted by award-winning journalist Daniel Levine. It focuses on the intersection of rare disease with business, science, and policy.

Share Targeting a Common Pathway in Genetic Forms of Obesity

Sign up to save your podcasts

Targeting a Common Pathway in Genetic Forms of Obesity

Targeting a Common Pathway in Genetic Forms of Obesity